Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Financial Report: AbbVie | Contract Pharma

What are you searching for?

Sign in
Financial News

Financial Report: AbbVie

Revenue in the quarter flat as Humira sales decline 6%

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

AbbVie  
1Q Revenues: $7.8 billion (flat)
1Q Earnings: $2.5 billion (-12%)
Comments: Global HUMIRA revenues were $4.4 billion in the quarter, down 6%. Global revenues from the hematologic oncology portfolio were up 43% to $1.2 billion. Global IMBRUVICA revenues were $1.0 billion, with U.S. net revenues of $829 million and international profit sharing of $193 million. Global VENCLEXTA revenues were $151 million. Global HCV revenues were $815 million, down 11%. In the U.S., HCV net revenues of $403 million grew 17% in the quarter.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters